Practice management involves overseeing all business aspects of a medical practice including financials, human resources, information technology, compliance, marketing and operations.
Cardiology faces one of its most challenging decades ahead, with mounting pressures from workforce shortages, an aging population and declining reimbursements. To remain sustainable, practices are forced to rethink how care is delivered from the ground up.
Effective Feb. 1, Blue Cross Blue Shield of North Carolina is no longer issuing separate payment for 3D rendering of imaging services (covered by CPT codes 76376 and 76377).
Cancer is by far the most commonly overlooked diagnosis at 45%, followed by infections (14%), vascular issues (7%) and cardiac concerns, according to new research.
Many adult survivors of childhood cancer are not concerned about their future health or developing new cancers, according to a new study published in Cancer.
It’s not every day that imaging equipment is used to scan a 68-million-year-old dinosaur skull, but that’s exactly what happened at George Washington University in Washington, D.C.
A high body mass index (BMI) may be associated with a reduced risk of premenopausal breast cancer, according to new research published in JAMA Oncology.
Radiology Partners announced Wednesday, June 27, that the research sector of its practice, Radiology Partners Research Institute (RPRI), “has seen early success in its scholarly efforts” since launching back in January.
Authors of a June 26 editorial in Annals of Internal Medicine advocated for a standard definition of "overdiagnosis" regarding cancer screenings, arguing poor understanding of the term is a threat that exposes patients to unnecessary treatments.
Women with dense breasts see higher cancer rates than their non-dense breast counterparts, suggesting additional screening might be beneficial, a nationwide study out of Norway has found.
A new study found ultra-high strength MRI may release toxic mercury from silver fillings, though commonly used 1.5 Tesla MRI machines appear to have no effect on the cavity-prone.
18F-Fluciclovine PET/CT can help detect previously undetected lesions in patients with biochemical recurrence of prostate cancer, according to a report presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting.